Prescription medication use during pregnancy and risk of infant leukemia (United States)

Cancer Causes and Control

Volumn 14, Issue 5, 2003, Pages 447-451

  Ross, Julie A ^a,d   Xie, Yang ^a   Davies, Stella M ^a   Shu, Xiao Ou ^b   Pendergrass, Thomas W ^c   Robison, Leslie L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

^d CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

Infant; Leukemia; Prescription drugs; Recall bias

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; BENDECTIN; CEFACLOR; CEFALEXIN; CLOMIFENE; CLOTRIMAZOLE; COCODAMOL; COTRIMOXAZOLE; DIPHENHYDRAMINE; ERYTHROMYCIN; HYDROCORTISONE; HYDROXYZINE; LEVOTHYROXINE; LOPERAMIDE; METRONIDAZOLE; MICONAZOLE; NITROFURANTOIN; NYSTATIN; PENICILLIN V POTASSIUM; PROCHLORPERAZINE; PROMETHAZINE; RHESUS D ANTIBODY; TERBUTALINE; THEOPHYLLINE DERIVATIVE; TRIMETHOBENZAMIDE; TRISULFAPYRIMIDINE; UNINDEXED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SAFETY; FEMALE; HUMAN; INFANT; INFANT DISEASE; LEUKEMIA; MAJOR CLINICAL STUDY; MEDICAL RECORD; PERINATAL DRUG EXPOSURE; PRESCRIPTION; PRIORITY JOURNAL; RISK; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; STATISTICAL SIGNIFICANCE;

CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, MYELOCYTIC, ACUTE; MATERNAL EXPOSURE; ODDS RATIO; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PRESCRIPTIONS, DRUG; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 0042232574     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024953532355     Document Type: Article

References (24)

1. Lenz W, Knapp K (1962) Die Thalidomid-Embryopathie. Dtsch Med Wochenschr 87: 1232-1242.
2. Rothman KJ, Moore LL, Singer MR, Nguyen US, Mannino S, Milunsky A (1995) Teratogenicity of high vitamin A intake. N Engl J Med 333: 1369-1373.
3. Herbst AL, Poskanzer DC, Robboy SJ, Frielander L, Scully RE (1975) Prenatal exposure to stilbestrol. A prospective comparison of exposed female offspring with unexposed controls. N Engl J Med 292: 334-339.
4. Stevenson RE, Allen WP, Pai GS, et al. (2000) Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics 106: 677-683.
5. Wiemels JL, Cazzaniga G, Daniotti M, et al. (1999) Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354: 1499-1503.
6. Ross JA, Davies SM, Potter JD, Robison LL (1994) Epidemiology of childhood leukemia, with a focus on infants. Epidemiol Rev 16: 243-272.
7. Shu XO, Reaman GH, Lampkin B, Sather HN, Pendergrass TW, Robison LL (1994) Association of paternal diagnostic X-ray exposure with risk of infant leukemia. Investigators of the Children's Cancer Group. Cancer Epidemiol Biomarkers Prev 3: 645-653.
8. Olson JE, Shu XO, Ross JA, Pendergrass T, Robison LL (1997) Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children's Cancer Group. Am J Epidemiol 145: 58-67.
9. Mertens AC, Wen W, Davies SM, et al. (1998) Congenital abnormalities in children with acute leukemia: a report from the Children's Cancer Group. J Pediatr 133: 617-623.
10. Wen WQ, Shu XO, Sellers T, Bhatia S, Lampkin B, Robison LL (1998) Family history of cancer and autoimmune disease and risk of leukemia in infancy: a report from the Children's Cancer Group (United States and Canada). Cancer Causes Control 9: 161-171.
11. Ross JA, Severson RK, Pollock BH, Robison LL (1996) Childhood cancer in the United States: a geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups. Cancer 77: 201-207.
12. Robison LL, Daigle AE (1984) Control selection using random digit dialing for cases of childhood cancer. Am J Epidemiol 120: 164-166.
13. Breslow NE, Day NE (1980) Statistical methods in cancer research, Vol. 1, The analysis of case-control studies. IARC scientific publication no. 32. Lyon: International Agency for Research on Cancer, pp. 5-338.
14. Lacy CF, Armstrong LL, Goldman MP, Lance LL (2001) Drug Information Handbook 2000-2001. Hudson, OH: Lexi-Comp Inc.
15. Principi N, Marchisio P, Biasini A, Dalla Villa A, Biasini G (1984) Early and late neutropenia in children treated with cotrimoxazole (trimethoprim-sulfamethoxazole). Acta Paediatr Scand 73: 763-767.
16. Bjornson BH, McIntrye AP, Harvey JM, Tauber AI (1986) Studies of the effects of trimethoprim and sulfamethoxazole on human granulopoiesis. Am J Hematol 23: 1-7.
17. Wiemels JL, Smith RN, Taylor GM, Eden OB, Alexander FE, Greaves MF (2001) Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA 98: 4004-4009.
18. Thompson JR, Gerald PF, Willoughby ML, Armstrong BK (2001) Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet 358: 1935-1940.
19. Rustia M, Shubik P (1972) Induction of lung tumors and malignant lymphomas in mice by metronidazole. J Natl Cancer Inst 48: 721-729.
20. Chacko M, Bhide SV (1986) Carcinogenicity, perinatal carcinogenicity and teratogenicity of low dose metronidazole (MNZ) in Swiss mice. J Cancer Res Clin Oncol 112: 135-140.
21. Thapa PB, Whitlock JA, Brockman Worrell KG, et al. (1998) Prenatal exposure to metronidazole and risk of childhood cancer. A retrospective cohort study of children younger than 5 years. Cancer 83: 1461-1468.
22. Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sorensen HT (2001) Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology 12: 461-466.
23. Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL (1996) Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia: a report from the Children's Cancer Group. Cancer Causes Control 7: 581-590.
24. Alexander FE, Patheal SL, Biondi A, et al. (2001) Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 61: 2542-2546.